can tirzepatide cause ulcers ๐ง Let's break the drug down using this mnemonic cloud!โ โ ๐ Tirzepatide is a GLP-1 and GIP agonist. โ โ ๐คBut what exactly is glucagon-like peptide (GLP-1) and gastric inhibitory polypeptide (GIP)? โ โ How Does Tirzepatide Work? |
Description
Common gastrointestinal side effects include: Nausea (reported in up to 44% of patients) Diarrhoea (approximately 30% of patients) Vomiting (24% of patients) Constipation (around 24% of patients) Abdominal pain (approximately 20% of patients) Dyspepsia and gastro-oesophageal reflux Flatulence and abdominal distension These effects are typically most pronounced during the initial weeks of treatment and during dose escalation

doi: 10.1038/s41392-023-01496-3, 6
Semaglutide 2.4 mg once weekly is the latest approved GLP-1 RA for obesity management (2021) and results in 1517% mean WL through appetite reduction [11, 12]

Nonarteritic Anterior Ischemic Optic Neuropathy and Semaglutide: What is This All About

& Singh, G.P
Prices match retail
